Aktie A14M4J LIFETECH SCIENTIFIC CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen LifeTech Scientific Corporation

Aktien

A14M4J

KYG548721177

1302

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:05 31.05.2024 		% 5 Tage % 1. Jan.
1,69 HKD +0,60 % Intraday Chart für LifeTech Scientific Corporation -4,52 % -28,09 %
16.05. LifeTech Scientific schließt Nachuntersuchung der klinischen Phase-2-Studie für IBS Coronary Scaffold ab MT
15.05. LifeTech Scientific Corporation gibt Ein-Jahres-Follow-up-Ergebnisse der klinischen Phase-II-Studie des bioresorbierbaren Koronargerüstsystems IBS Sirolimus-Eluting Iron bekannt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
LifeTech Scientific Completes Follow-up of Phase 2 Clinical Study of IBS Coronary Scaffold
LifeTech Scientific Corporation Announces One-Year Follow-Up Results of Phase II Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
Lifetech Scientific Buys Shares For Employee Incentive Scheme
Lifetech Scientific Unit Invests 340 Million Yuan in Structured Deposits
Lifetech Scientific Books Lower 2023 Profit Despite Surge in Revenue
LifeTech Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
LifeTech Scientific Flags Significant Profit Drop in 2023
Lifetech Scientific Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023
LifeTech Scientific to Grant 174.8 Million Share Options
LifeTech Scientific Gets Regulatory Nod to Register Peripheral Thrombus Aspiration Catheter
LifeTech Scientific's H1 Attributable Profit Grows on Higher Revenue
LifeTech Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
Epione Surgical Navigation System Obtained Official Registration Approval by the China NMPA
LifeTech Scientific Unit Invests 50 Million Yuan in Structured Deposit Product by Bank of Ningbo
LifeTech Scientific Completes Patient Enrollment for Phase 3 Study of Coronary Scaffold System
Lifetech Scientific Corporation Announces Enrollment in the Phase Iii Clinical Study of Ibs®? Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed
LifeTech Scientific Corporation Announces Publication of the Three-Year Follow-Up Results of FIM Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System
LifeTech Scientific Logs 68.6% Drop in 2022 Profit
LifeTech Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Lifetech Scientific and Jenscare Scientific to Cooperate on Business Development
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14M4J Aktie
  4. Nachrichten LifeTech Scientific Corporation
  5. Andere Sprachen